Ingo Helbig

20.0k total citations
124 papers, 2.8k citations indexed

About

Ingo Helbig is a scholar working on Genetics, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Ingo Helbig has authored 124 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Genetics, 50 papers in Psychiatry and Mental health and 46 papers in Molecular Biology. Recurrent topics in Ingo Helbig's work include Genetics and Neurodevelopmental Disorders (53 papers), Genomics and Rare Diseases (50 papers) and Epilepsy research and treatment (49 papers). Ingo Helbig is often cited by papers focused on Genetics and Neurodevelopmental Disorders (53 papers), Genomics and Rare Diseases (50 papers) and Epilepsy research and treatment (49 papers). Ingo Helbig collaborates with scholars based in United States, Germany and United Kingdom. Ingo Helbig's co-authors include Samuel F. Berkovic, Ingrid E. Scheffer, Katherine L. Helbig, John C. Mulley, Daniel H. Lowenstein, Ahmad Abou Tayoun, Rikke S. Møller, Heather C. Mefford, Zöe Powis and Cameron Mroske and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neuron and SHILAP Revista de lepidopterología.

In The Last Decade

Ingo Helbig

112 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingo Helbig United States 30 1.3k 1.1k 1.0k 648 332 124 2.8k
Sarah Weckhuysen Belgium 26 860 0.7× 961 0.8× 1.0k 1.0× 584 0.9× 339 1.0× 71 2.3k
Lynette G. Sadleir New Zealand 24 813 0.6× 1.4k 1.3× 576 0.6× 570 0.9× 538 1.6× 66 2.3k
Yuwu Jiang China 30 869 0.7× 842 0.7× 1.6k 1.6× 905 1.4× 400 1.2× 227 3.2k
Bruria Ben‐Zeev Israel 33 994 0.8× 892 0.8× 1.3k 1.3× 737 1.1× 514 1.5× 105 3.4k
Marina Trivisano Italy 25 644 0.5× 875 0.8× 460 0.4× 307 0.5× 406 1.2× 104 1.7k
Andreas Brunklaus United Kingdom 22 622 0.5× 1.0k 0.9× 560 0.5× 358 0.6× 458 1.4× 47 1.8k
Sara Kivity Israel 24 549 0.4× 1.5k 1.3× 449 0.4× 615 0.9× 795 2.4× 61 2.2k
Kenji Sugai Japan 27 467 0.4× 1.0k 0.9× 862 0.8× 552 0.9× 760 2.3× 213 2.8k
Stefan Johansson Norway 35 1.6k 1.2× 511 0.4× 1.4k 1.3× 264 0.4× 219 0.7× 111 4.0k
Giuseppe Gobbi Italy 28 551 0.4× 1.2k 1.1× 435 0.4× 433 0.7× 649 2.0× 85 2.1k

Countries citing papers authored by Ingo Helbig

Since Specialization
Citations

This map shows the geographic impact of Ingo Helbig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingo Helbig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingo Helbig more than expected).

Fields of papers citing papers by Ingo Helbig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingo Helbig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingo Helbig. The network helps show where Ingo Helbig may publish in the future.

Co-authorship network of co-authors of Ingo Helbig

This figure shows the co-authorship network connecting the top 25 collaborators of Ingo Helbig. A scholar is included among the top collaborators of Ingo Helbig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingo Helbig. Ingo Helbig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Galer, Peter D., Jillian L. McKee, Sarah M. Ruggiero, et al.. (2025). Quantitative EEG Biomarkers in the Genetic Epilepsies and Associations With Neurologic Outcomes. Neurology. 105(8). e214148–e214148.
2.
Budnik, Nikita, Siwei Chen, David Báez-Nieto, et al.. (2025). Characterization of the functional and clinical impacts of CACNA1A missense variants found in neurodevelopmental disorders. Science Translational Medicine. 17(828). eadr0024–eadr0024.
3.
Ruggiero, Sarah M., Julie Xian, Shridhar Parthasarathy, et al.. (2024). The clinical and genetic spectrum of paediatric speech and language disorders. Brain. 148(2). 663–674. 4 indexed citations
4.
Xian, Julie, Shridhar Parthasarathy, Michael J. Boland, et al.. (2024). Early life seizures and epileptic spasms in STXBP1‐related disorders. Epilepsia. 65(3). 805–816. 6 indexed citations
5.
Vanoye, Carlos G., Madeleine J. Oudin, Christopher B. Burge, et al.. (2024). Molecular and cellular context influences SCN8A variant function. JCI Insight. 9(12). 9 indexed citations
6.
Galer, Peter D., David Lewis‐Smith, Shridhar Parthasarathy, et al.. (2023). Enriching representation learning using 53 million patient notes through human phenotype ontology embedding. Artificial Intelligence in Medicine. 139. 102523–102523. 10 indexed citations
7.
Hanin, Aurélie, Eleonora Aronica, Ingo Helbig, et al.. (2023). Review and standard operating procedures for collection of biospecimens and analysis of biomarkers innew onsetrefractory status epilepticus. Epilepsia. 64(6). 1444–1457. 7 indexed citations
8.
Brock, Trisha, et al.. (2023). Clinical variants in Caenorhabditis elegans expressing human STXBP1 reveal a novel class of pathogenic variants and classify variants of uncertain significance. SHILAP Revista de lepidopterología. 1(1). 100823–100823. 4 indexed citations
9.
Dlugos, Dennis, Mark P. Fitzgerald, Laurence E. Fried, et al.. (2023). A quality improvement initiative to improve folic acid supplementation counseling for adolescent females with epilepsy. Epilepsia. 64(10). 2818–2826.
10.
Kaufman, Michael C., Julie Xian, Peter D. Galer, et al.. (2022). Child neurology telemedicine: Analyzing 14 820 patient encounters during the first year of the COVID ‐19 pandemic. Developmental Medicine & Child Neurology. 65(3). 406–415. 1 indexed citations
11.
Havrilla, James M., et al.. (2022). PheNominal: an EHR-integrated web application for structured deep phenotyping at the point of care. BMC Medical Informatics and Decision Making. 22(S2). 198–198. 6 indexed citations
12.
Kaufman, Michael C., Alexander K. Gonzalez, Jennifer MacDonald, et al.. (2022). Ketamine for Management of Neonatal and Pediatric Refractory Status Epilepticus. Neurology. 99(12). e1227–e1238. 39 indexed citations
13.
Hammer, Michael F., Medhane Cumbay, Manuela Pendziwiat, et al.. (2022). Whole exome sequencing and co‐expression analysis identify an SCN1A variant that modifies pathogenicity in a family with genetic epilepsy and febrile seizures plus. Epilepsia. 63(8). 1970–1980. 4 indexed citations
14.
Vanoye, Carlos G., Reshma R. Desai, Zhigang Ji, et al.. (2022). High-throughput evaluation of epilepsy-associated KCNQ2 variants reveals functional and pharmacological heterogeneity. JCI Insight. 7(5). 28 indexed citations
15.
Oliver, Karen, Colin A. Ellis, Ingrid E. Scheffer, et al.. (2022). Common risk variants for epilepsy are enriched in families previously targeted for rare monogenic variant discovery. EBioMedicine. 81. 104079–104079. 17 indexed citations
16.
Gonzalez, Alexander K., Michael C. Kaufman, Julie Xian, et al.. (2022). Visits of concern in child neurology telemedicine. Developmental Medicine & Child Neurology. 64(11). 1351–1358. 6 indexed citations
17.
Knowles, Juliet K., Ingo Helbig, Cameron S. Metcalf, et al.. (2022). Precision medicine for genetic epilepsy on the horizon: Recent advances, present challenges, and suggestions for continued progress. Epilepsia. 63(10). 2461–2475. 65 indexed citations
18.
Fitzgerald, Mark P., Michael C. Kaufman, Shavonne L. Massey, et al.. (2021). Assessing seizure burden in pediatric epilepsy using an electronic medical record–based tool through a common data element approach. Epilepsia. 62(7). 1617–1628. 17 indexed citations
19.
Carvill, Gemma L., Ingo Helbig, & Heather C. Mefford. (2015). CHD2-Related Neurodevelopmental Disorders. 8 indexed citations
20.
Abend, Nicholas S., David Bearden, Ingo Helbig, et al.. (2014). Status Epilepticus and Refractory Status Epilepticus Management. Seminars in Pediatric Neurology. 21(4). 263–274. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah Weckhuysen Breakdown of academic impact, for papers by Lynette G. Sadleir Breakdown of academic impact, for papers by Yuwu Jiang Breakdown of academic impact, for papers by Bruria Ben‐Zeev Breakdown of academic impact, for papers by Marina Trivisano Breakdown of academic impact, for papers by Andreas Brunklaus Breakdown of academic impact, for papers by Sara Kivity Breakdown of academic impact, for papers by Kenji Sugai Breakdown of academic impact, for papers by Stefan Johansson Breakdown of academic impact, for papers by Giuseppe Gobbi
Rankless by CCL
2026